Work with thought leaders and academic experts in pharmacy

Companies can greatly benefit from working with experts in the field of Pharmacy. These researchers bring a wealth of knowledge and experience that can enhance various aspects of a company's operations. Here are some ways companies can collaborate with academic researchers in Pharmacy: 1. Research and Development: Academic researchers can contribute to the development of new drugs, therapies, and treatment methods. Their expertise can help companies in the pharmaceutical industry stay at the forefront of innovation. 2. Clinical Trials: Researchers can assist in designing and conducting clinical trials for new drugs. Their knowledge of regulatory requirements and ethical considerations ensures the trials are conducted effectively and safely. 3. Drug Safety and Efficacy: Academic researchers can evaluate the safety and efficacy of existing drugs. Their findings can help companies improve their products and ensure patient safety. 4. Pharmacovigilance: Researchers can monitor and analyze adverse drug reactions and provide insights into drug safety. This helps companies identify potential risks and take appropriate measures. 5. Education and Training: Academic researchers can provide training and education to company employees, keeping them updated on the latest advancements in Pharmacy. 6. Collaboration on Grants and Funding: Researchers can collaborate with companies on grant applications and funding opportunities, leveraging their expertise to secure funding for research projects. 7. Regulatory Compliance: Academic researchers can assist companies in navigating complex regulatory frameworks and ensuring compliance with industry standards. 8. Market Research: Researchers can conduct market research to identify trends, consumer preferences, and competitive landscapes. This information helps companies make informed decisions and develop effective marketing strategies. By collaborating with academic researchers in Pharmacy, companies can tap into a vast pool of knowledge and expertise, leading to improved products, enhanced research capabilities, and a competitive edge in the industry.

Experts on NotedSource with backgrounds in pharmacy include Luke Connelly, Jonathan D. Agnew, PhD, MBA, Sheraz Ch, Nitin Pandey, Parisa Lotfi, and Michael Avaltroni.

Luke Connelly

Professor of Health Economics, The University of Queensland, CBEH
Most Relevant Research Interests
Other Research Interests (51)
Health economics
Public Health, Environmental and Occupational Health
Safety, Risk, Reliability and Quality
Human Factors and Ergonomics
And 46 more
Luke Connelly is Professor of Health Economics at the Centre for the Business and Economics of Health. He also holds a Professorial appointment (part-time) at The University of Bologna, to which he was appointed in 2017 via the Italian “Direct Call” ([link]( process. In 2019 he was appointed as Honorary Professor at The University of Sydney. His main interests are in health economics and insurance economics and the effects of institutions (including legal constructs) on incentives and behaviour. He has also worked in other fields of applied microeconomics, including education economics and transport economics. His publications include papers in *Review of Income and Wealth*, *Health Economics*, *Journal of Health Economics*, *Journal of Risk and Insurance*, *Geneva Papers on Risk and Insurance*, *Accident Analysis and Prevention*, *Journal of Law and Medicine*, *Journal of Clinical Epidemiology*, *European Journal of Health Economics*, *International Journal of Health Economics and Finance*, *Social Science and Medicine*, *Economic Papers*, *Economic Analysis and Policy*, *Journal of Transport Economics and Policy*, *Labour Economics*, *Economics and Human Biology* as well as in a range of clinical journals, including *Lancet*. Luke has served on a number of public committees including the Medical Services Advisory Committee (MSAC), which advises the Australian Minister for Health on the safety, efficacy, effectiveness, and cost-effectiveness of new and extant listings on Australia's Medicare Benefits Schedule. He has extensive service on other public committees and taskforces as well as extensive teaching and consulting engagements with industry. Over his career he has been a chief investigator on research grants and contracts totalling more than $67m. He is a member of the Editorial Boards of European Journal of Health Economics and the International Journal on Environmental Research and Public Health. He is a member of the International Health Economics Association's Arrow Awards Committee, which awards an annual prize in honour of Nobel Laureate Kenneth Arrow for the best paper in the field. He is currently Guest Editor (with Christophe Courbage) on a Special Issue of the Geneva Papers on Risk and Insurance on Insurance and Emerging Health Risks. His current research interests include health service innovations to improve the health of people with chronic kidney disease(CKD). Ongoing interests include the economics of disability and insurance, compensable injury compensation schemes, and the determinants of health. Luke enjoys and has considerable experience teaching economics and health economics at both the graduate and undergraduate levels. In 2014 he was awarded the School of Economics Distinguished Teaching Award for his teaching on UQ's Master of Health Economics Program. In July 2016 and July 2019 he also taught summer schools in Health Economics and the Economics of Insurance at The University of Lucerne, Switzerland. Over the past 10 years he has been a chief investigator on grants totalling more than $70m.
Most Relevant Publications (1+)

105 total publications

Impact of pharmacist and physician collaborations in primary care on reducing readmission to hospital: A systematic review and meta-analysis

Research in Social and Administrative Pharmacy / Jun 01, 2022

Foot, H., Scott, I., Sturman, N., Whitty, J. A., Rixon, K., Connelly, L., Williams, I., & Freeman, C. (2022). Impact of pharmacist and physician collaborations in primary care on reducing readmission to hospital: A systematic review and meta-analysis. Research in Social and Administrative Pharmacy, 18(6), 2922–2943.

Sheraz Ch

1DANA Brain Health Institute, Iranian Neuroscience Society-Fars Chapter, Shiraz, Iran 2Senses Cultural Foundation, Sacramento, CA, USA
Most Relevant Research Interests
Other Research Interests (17)
Machine learning
Brain disorder
Deep learning
Brain signal processing
And 12 more
Most Relevant Publications (2+)

15 total publications

Hospital pharmacists’ awareness and perspective toward the management of COVID-19 pandemic in the Kingdom of Saudi Arabia

Pharmacy Practice / Sep 23, 2022

Salem Al-Dossari, D., Abdulaziz Al-Zaagi, I., Bamogaddam, R. F., Hamoud Alnajrani, R., Rashid Alnajrani, N., Najib Alajami, H., Abdullah AlOtaibi, R., AlShammary, K. S., AlOtaibi, A. J., Yousaf, A., & Ali, S. (2022). Hospital pharmacists’ awareness and perspective toward the management of COVID-19 pandemic in the Kingdom of Saudi Arabia. Pharmacy Practice, 20(3), 01–07.

Knowledge and Barriers Among Physicians Toward Adverse Drug Reaction Reporting at a Tertiary Care Hospital in Saudi Arabia

Hospital Pharmacy / Mar 04, 2020

Al-Abdulkarim, D. A., Aljadhey, H. S., Mahmoud, M. A., Poff, G. A., Hassali, M. A., & Ali, S. (2020). Knowledge and Barriers Among Physicians Toward Adverse Drug Reaction Reporting at a Tertiary Care Hospital in Saudi Arabia. Hospital Pharmacy, 56(4), 368–373.

Example pharmacy projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on pharmacy?

Development of Novel Drug Delivery Systems

An academic researcher in Pharmacy can collaborate with a pharmaceutical company to develop innovative drug delivery systems. This can include the design of nanoparticles, liposomes, or implants that improve drug efficacy and patient compliance.

Pharmacogenomics Research

Companies can benefit from collaborating with a Pharmacy researcher in pharmacogenomics. This field focuses on understanding how an individual's genetic makeup influences their response to drugs. By incorporating pharmacogenomic data into drug development, companies can create personalized treatment options.

Drug Repurposing Studies

Academic researchers can collaborate with companies to explore the potential of repurposing existing drugs for new indications. This can lead to cost-effective solutions and faster development timelines, as the safety profiles of these drugs are already established.

Pharmacy Automation and Robotics

Collaborating with a Pharmacy researcher specializing in automation and robotics can help companies streamline their operations. This includes the development of automated dispensing systems, robotic medication compounding, and inventory management solutions.

Pharmaceutical Policy and Health Economics

Companies can benefit from the expertise of Pharmacy researchers in pharmaceutical policy and health economics. These researchers can provide insights into pricing strategies, market access, and cost-effectiveness analyses, helping companies optimize their business strategies.